000 01382 a2200373 4500
005 20250516021128.0
264 0 _c20110509
008 201105s 0 0 eng d
022 _a1742-4658
024 7 _a10.1111/j.1742-4658.2011.08017.x
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aNaudé, Petrus J W
245 0 0 _aTumor necrosis factor receptor cross-talk.
_h[electronic resource]
260 _bThe FEBS journal
_cApr 2011
300 _a888-98 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAnimals
650 0 4 _aCell Survival
_xphysiology
650 0 4 _aHumans
650 0 4 _aMice
650 0 4 _aNF-kappa B
_xmetabolism
650 0 4 _aReceptor Cross-Talk
_xphysiology
650 0 4 _aReceptors, Tumor Necrosis Factor, Type I
_xphysiology
650 0 4 _aReceptors, Tumor Necrosis Factor, Type II
_xphysiology
650 0 4 _aSignal Transduction
_xphysiology
650 0 4 _aTNF Receptor-Associated Factor 1
_xphysiology
650 0 4 _aTNF Receptor-Associated Factor 2
_xphysiology
650 0 4 _aTumor Necrosis Factor-alpha
_xphysiology
700 1 _aden Boer, Johan A
700 1 _aLuiten, Paul G M
700 1 _aEisel, Ulrich L M
773 0 _tThe FEBS journal
_gvol. 278
_gno. 6
_gp. 888-98
856 4 0 _uhttps://doi.org/10.1111/j.1742-4658.2011.08017.x
_zAvailable from publisher's website
999 _c20515079
_d20515079